Cargando…
More Haste, Less Speed: Could Public–Private Partnerships Advance Cellular Immunotherapies?
Cellular immunotherapies promise to transform cancer care. However, they must overcome serious challenges, including: (1) the need to identify and characterize novel cancer antigens to expand the range of therapeutic targets; (2) the need to develop strategies to minimize serious adverse events, suc...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561330/ https://www.ncbi.nlm.nih.gov/pubmed/28861415 http://dx.doi.org/10.3389/fmed.2017.00134 |